Sign in
4

Changes in Ownership

Janux Therapeutics, Inc. Filed Acc 0001415889-24-018452

Director acquired 2,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

RA CAPITAL MANAGEMENT, L.P. · Director

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2024-06-26 Grant or award : show line 1 in the form +2,500 2,500 I

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-06-26 Grant or award : show line 2 in the form Stock Option (Right to Buy) +8,350 8,350 I
Loading xslF345X05/form4-06282024_080632.xml…